MIEIX
Price
$40.95
Change
+$0.16 (+0.39%)
Updated
Nov 12 closing price
Net Assets
30.76B
VTIAX
Price
$40.68
Change
+$0.20 (+0.49%)
Updated
Nov 12 closing price
Net Assets
554.27B
Interact to see
Advertisement

MIEIX vs VTIAX

Header iconMIEIX vs VTIAX Comparison
Open Charts MIEIX vs VTIAXBanner chart's image
MFS International Equity R6
Price$40.95
Change+$0.16 (+0.39%)
VolumeN/A
Net Assets30.76B
Vanguard Total Intl Stock Index Admiral
Price$40.68
Change+$0.20 (+0.49%)
VolumeN/A
Net Assets554.27B
MIEIX vs VTIAX Comparison Chart in %
View a ticker or compare two or three
VS
MIEIX vs. VTIAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIEIX is a Hold and VTIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTIAX has more cash in the bank: 554B vs. MIEIX (30.8B). VTIAX pays higher dividends than MIEIX: VTIAX (2.70) vs MIEIX (1.23). MIEIX was incepted earlier than VTIAX: MIEIX (30 years) vs VTIAX (15 years). MIEIX (0.70) is less costly to investors than VTIAX (0.09). MIEIX is a more actively managed with annual turnover of: 13.00 vs. VTIAX (3.00). MIEIX has a lower initial minimum investment than VTIAX: MIEIX (0) vs VTIAX (3000). VTIAX annual gain was more profitable for investors over the last year : 25.12 vs. MIEIX (18.73). MIEIX return over 5 years is better than : 48.25 vs. VTIAX (39.59).
MIEIXVTIAXMIEIX / VTIAX
Total Expense Ratio0.690.09767%
Annual Report Gross Expense Ratio0.700.09778%
Fund Existence30 years15 years-
Gain YTD21.08228.91273%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets30.8B554B6%
Annual Yield % from dividends1.232.7046%
Returns for 1 year18.7325.1275%
Returns for 3 years48.3249.2898%
Returns for 5 years48.2539.59122%
Returns for 10 years118.7979.35150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.280.21
+10.14%
Acrivon Therapeutics
MRNA26.710.30
+1.14%
Moderna
EGHAU10.55N/A
N/A
EGH Acquisition Corp.
RAMP30.46-0.42
-1.36%
LiveRamp Holdings
IMRX6.62-0.12
-1.78%
Immuneering Corp